Abeona Therapeutics (ABEO) Amortizatization of Intangibles (2019 - 2026)
Abeona Therapeutics' (ABEO) quarterly Amortizatization of Intangibles came in at -$13000.0 in Q1 2026, up 97.14% year-on-year from -$6594.2 in Q1 2025, and up 98.11% quarter-over-quarter from -$687000.0 in Q4 2025.
Abeona Therapeutics (ABEO) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends
Abeona Therapeutics' Amortizatization of Intangibles history runs 8 years deep, the most recent figure standing at -$13000.0 for Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles rose 97.14% year-over-year to -$13000.0 in Q1 2026; TTM through Mar 2026 was -$447000.0, a 43.42% increase from a year earlier, with the FY2025 full-year figure at -$889000.0, down 222.1% from the prior year.
- Amortizatization of Intangibles advanced to -$13000.0 in Q1 2026 per ABEO's latest filing, from -$687000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $227000.0 in Q4 2023 and bottomed at -$687000.0 in Q4 2025.
- The 5-year median for Amortizatization of Intangibles is $29000.0 (2022), against an average of -$41470.6.
- Biggest YoY gain for Amortizatization of Intangibles was 2257.14% in 2025; the steepest drop was 871.19% in 2025.
- Year by year, Amortizatization of Intangibles stood at $174000.0 in 2022, then surged by 30.46% to $227000.0 in 2023, then plunged by 197.8% to -$222000.0 in 2024, then tumbled by 209.46% to -$687000.0 in 2025, then jumped by 98.11% to -$13000.0 in 2026.
- Per Business Quant, the three latest ABEO Amortizatization of Intangibles figures stand at -$13000.0 (Q1 2026), -$687000.0 (Q4 2025), and $88000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Abeona Therapeutics | 347.09 Mn | 178.82 Mn | 6.02 Mn | -13,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13,000.00 |
| Mar 31, 2026 | -13,000.00 |
| Dec 31, 2025 | -687,000.00 |
| Dec 31, 2025 | -687,000.00 |
| Sep 30, 2025 | 88,000.00 |
| Sep 30, 2025 | 88,000.00 |
| Jun 30, 2025 | 165,000.00 |
| Jun 30, 2025 | 165,000.00 |
| Mar 31, 2025 | -455,000.00 |
| Mar 31, 2025 | -455,000.00 |
| Dec 31, 2024 | -222,000.00 |
| Dec 31, 2024 | -222,000.00 |
| Sep 30, 2024 | -120,000.00 |
| Sep 30, 2024 | -120,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Mar 31, 2024 | 59,000.00 |
| Mar 31, 2024 | 59,000.00 |
| Dec 31, 2023 | 227,000.00 |
| Dec 31, 2023 | 227,000.00 |